Variant report
Variant | nsv564455 |
---|---|
Chromosome Location | chr14:40717843-40789139 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:40457857..40458829-chr14:40749466..40750494,4 | MCF-7 | breast: | |
2 | chr14:40691066..40691614-chr14:40740770..40741278,2 | MCF-7 | breast: | |
3 | chr14:40721840..40722668-chr15:81828412..81828932,3 | MCF-7 | breast: | |
4 | chr14:40762742..40765094-chr14:40766225..40768679,2 | K562 | blood: | |
5 | chr14:40762742..40765094-chr14:40766225..40768679,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1950223 | chr14:40717843-40717844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574945540 | chr14:40717844-40717845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543987810 | chr14:40717865-40717866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186963696 | chr14:40717896-40717897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370334582 | chr14:40717930-40717931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546300981 | chr14:40717974-40717975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559811502 | chr14:40717976-40717977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537073155 | chr14:40718010-40718011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533569294 | chr14:40718018-40718019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373460213 | chr14:40718019-40718020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528458078 | chr14:40718035-40718036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145187092 | chr14:40718078-40718079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561975441 | chr14:40718096-40718097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530619913 | chr14:40718100-40718101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574487266 | chr14:40718130-40718131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149615157 | chr14:40718142-40718143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376672240 | chr14:40718248-40718249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61417653 | chr14:40718268-40718269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528435615 | chr14:40718291-40718292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190049993 | chr14:40718294-40718295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138800195 | chr14:40718319-40718320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375587085 | chr14:40740601-40740602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181848604 | chr14:40740606-40740607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185225385 | chr14:40740615-40740616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113836324 | chr14:40740639-40740640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115470347 | chr14:40740661-40740662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147515652 | chr14:40740734-40740735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536225574 | chr14:40740895-40740896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77440671 | chr14:40740941-40740942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548526743 | chr14:40740949-40740950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72667432 | chr14:40740954-40740955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530925099 | chr14:40740961-40740962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181915704 | chr14:40740996-40740997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550411689 | chr14:40753009-40753010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563842756 | chr14:40753032-40753033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17110417 | chr14:40753040-40753041 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs552596599 | chr14:40753046-40753047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566040798 | chr14:40753090-40753091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535048279 | chr14:40753126-40753127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140713928 | chr14:40753153-40753154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17110419 | chr14:40753184-40753185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs536920623 | chr14:40753186-40753187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145909233 | chr14:40753202-40753203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551501922 | chr14:40753250-40753251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369076959 | chr14:40753255-40753256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566530424 | chr14:40753316-40753317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374817872 | chr14:40753383-40753384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576929074 | chr14:40753398-40753399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539247531 | chr14:40753421-40753422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113620949 | chr14:40753424-40753425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21298110 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 22102821 | CNVD |
Schizophrenia | 23813976 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Schizophrenia | 19805367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:40717800-40718400 | Enhancers | Fetal Kidney | kidney |
2 | chr14:40740600-40741000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr14:40740600-40741000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr14:40753000-40753200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr14:40753200-40753800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr14:40753800-40754400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr14:40755200-40756000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr14:40756400-40756800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr14:40761000-40763600 | Enhancers | Primary B cells from cord blood | blood |
10 | chr14:40761400-40761600 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr14:40761600-40762200 | Weak transcription | Primary B cells from peripheral blood | blood |
12 | chr14:40762200-40763400 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr14:40763000-40763200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr14:40777000-40777200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr14:40777000-40777200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr14:40777000-40787400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
17 | chr14:40782000-40782400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr14:40787400-40788000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
19 | chr14:40787400-40788000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr14:40787400-40788000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr14:40787600-40788000 | Enhancers | HUES48 Cell Line | embryonic stem cell |